---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-016711"
form_type: "8-K"
ticker: "CRDF"
cik: "0001213037"
company_name: "Cardiff Oncology, Inc."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:03:39.265659+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# All proposals pass at Cardiff annual meeting; say-on-pay vote splits nearly evenly

## Summary
- All seven director nominees elected; votes for ranged 14.2M–17.0M, with ~12M broker non-votes.
- BDO USA ratified as auditor: 28.7M for, 487.9K against, 172.4K abstain.
- Amendment to 2021 Omnibus Equity Incentive Plan approved: 14.0M for, 3.1M against, 172.1K abstain.
- Advisory vote on executive compensation approved narrowly: 7.93M for, 7.36M against, 2.02M abstain.

## SEC filing metadata
- accession: 0001628280-22-016711
- form_type: 8-K
- ticker: CRDF
- cik: 0001213037
- company_name: Cardiff Oncology, Inc.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213037/000162828022016711/0001628280-22-016711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213037/000162828022016711/crdf-20220609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-016711
- JSON: https://secwatch.observer/filing/0001628280-22-016711.json
- Plain text: https://secwatch.observer/filing/0001628280-22-016711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.